These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12753811)
21. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis. Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636 [TBL] [Abstract][Full Text] [Related]
22. Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice. Wang JJ; Yang GX; Zhang WC; Lu L; Tsuneyama K; Kronenberg M; Véla JL; Lopez-Hoyos M; He XS; Ridgway WM; Leung PS; Gershwin ME Clin Exp Immunol; 2014 Feb; 175(2):192-201. PubMed ID: 24128311 [TBL] [Abstract][Full Text] [Related]
23. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. Long SA; Quan C; Van de Water J; Nantz MH; Kurth MJ; Barsky D; Colvin ME; Lam KS; Coppel RL; Ansari A; Gershwin ME J Immunol; 2001 Sep; 167(5):2956-63. PubMed ID: 11509645 [TBL] [Abstract][Full Text] [Related]
24. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289 [TBL] [Abstract][Full Text] [Related]
25. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases. Matsumura S; Van De Water J; Kita H; Coppel RL; Tsuji T; Yamamoto K; Ansari AA; Gershwin ME Hepatology; 2002 Jan; 35(1):14-22. PubMed ID: 11786955 [TBL] [Abstract][Full Text] [Related]
27. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis. Nishio A; Coppel R; Ishibashi H; Gershwin ME Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013 [TBL] [Abstract][Full Text] [Related]
28. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. Rowley MJ; Scealy M; Whisstock JC; Jois JA; Wijeyewickrema LC; Mackay IR J Immunol; 2000 Mar; 164(6):3413-9. PubMed ID: 10706737 [TBL] [Abstract][Full Text] [Related]
29. Analysis of T-cell receptor beta of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis. Ichiki Y; Shimoda S; Hara H; Shigematsu H; Nakamura M; Hayashida K; Ishibashi H; Niho Y Hepatology; 1997 Sep; 26(3):728-33. PubMed ID: 9303504 [TBL] [Abstract][Full Text] [Related]
30. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Bogdanos DP; Baum H; Okamoto M; Montalto P; Sharma UC; Rigopoulou EI; Vlachogiannakos J; Ma Y; Burroughs AK; Vergani D Hepatology; 2005 Aug; 42(2):458-65. PubMed ID: 16025495 [TBL] [Abstract][Full Text] [Related]
31. [Prediction and identification of autoepitopes of PDC-E2 specific CD8+ CTL in primary biliary cirrhosis patients]. Liu HY; Yao DK; Tu XQ; Zhou Y; Zhu Y; Chen Y; Fan LY; Zhong RQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):500-4. PubMed ID: 15562760 [TBL] [Abstract][Full Text] [Related]
32. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Yeaman SJ; Kirby JA; Jones DE Immunol Rev; 2000 Apr; 174():238-49. PubMed ID: 10807520 [TBL] [Abstract][Full Text] [Related]
33. TCRβ repertoire of memory T cell reveals potential role for Escherichia coli in the pathogenesis of primary biliary cholangitis. Hou X; Yang Y; Chen J; Jia H; Zeng P; Lv L; Lu Y; Liu X; Diao H Liver Int; 2019 May; 39(5):956-966. PubMed ID: 30721553 [TBL] [Abstract][Full Text] [Related]
34. A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis. Tuaillon N; Andre C; Briand JP; Penner E; Muller S J Immunol; 1992 Jan; 148(2):445-50. PubMed ID: 1729364 [TBL] [Abstract][Full Text] [Related]
35. Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. Kita H; Matsumura S; He XS; Ansari AA; Lian ZX; Van de Water J; Coppel RL; Kaplan MM; Gershwin ME Hepatology; 2002 Oct; 36(4 Pt 1):918-26. PubMed ID: 12297839 [TBL] [Abstract][Full Text] [Related]
37. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Klein R; Wiebel M; Engelhart S; Berg PA Clin Exp Immunol; 1993 May; 92(2):308-16. PubMed ID: 7683589 [TBL] [Abstract][Full Text] [Related]
38. Proteasome is required for class I-restricted presentation by Fcgamma receptor-mediated endocytosis in primary biliary cirrhosis. Kita H; Ansari AA; He XS; Lian ZX; Van de Water J; Coppel RL; Luketic V; Kaplan M; Inamori H; Isoda N; Sugano K; Imawari M; Gershwin ME J Autoimmun; 2003 Sep; 21(2):175-82. PubMed ID: 12935787 [TBL] [Abstract][Full Text] [Related]
39. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370 [TBL] [Abstract][Full Text] [Related]
40. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. Surh CD; Coppel R; Gershwin ME J Immunol; 1990 May; 144(9):3367-74. PubMed ID: 1691756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]